In the past week, EVH stock has gone up by 2.49%, with a monthly decline of -10.39% and a quarterly plunge of -33.11%. The volatility ratio for the week is 6.51%, and the volatility levels for the last 30 days are 5.11% for Evolent Health Inc The simple moving average for the last 20 days is -1.67% for EVH stock, with a simple moving average of -29.34% for the last 200 days.
Is It Worth Investing in Evolent Health Inc (NYSE: EVH) Right Now?
Moreover, the 36-month beta value for EVH is 1.55. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 7 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EVH is 110.59M and currently, short sellers hold a 11.33% of that float. On July 23, 2024, EVH’s average trading volume was 1.77M shares.
EVH) stock’s latest price update
Evolent Health Inc (NYSE: EVH) has seen a rise in its stock price by 0.25 in relation to its previous close of 19.69. However, the company has experienced a 2.49% gain in its stock price over the last five trading sessions. zacks.com reported 2024-07-17 that Evolent Health (EVH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Analysts’ Opinion of EVH
Many brokerage firms have already submitted their reports for EVH stocks, with Citigroup repeating the rating for EVH by listing it as a “Buy.” The predicted price for EVH in the upcoming period, according to Citigroup is $40 based on the research report published on April 22, 2024 of the current year 2024.
Oppenheimer, on the other hand, stated in their research note that they expect to see EVH reach a price target of $45. The rating they have provided for EVH stocks is “Outperform” according to the report published on March 01st, 2024.
Barclays gave a rating of “Overweight” to EVH, setting the target price at $39 in the report published on January 03rd of the current year.
EVH Trading at -9.70% from the 50-Day Moving Average
After a stumble in the market that brought EVH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.60% of loss for the given period.
Volatility was left at 5.11%, however, over the last 30 days, the volatility rate increased by 6.51%, as shares sank -12.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.61% lower at present.
During the last 5 trading sessions, EVH rose by +2.49%, which changed the moving average for the period of 200-days by -24.34% in comparison to the 20-day moving average, which settled at $19.94. In addition, Evolent Health Inc saw -40.24% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EVH starting from Blackley Seth, who sale 141,000 shares at the price of $26.54 back on Dec 05 ’23. After this action, Blackley Seth now owns 637,645 shares of Evolent Health Inc, valued at $3,741,475 using the latest closing price.
McCarthy Daniel Joseph, the PRESIDENT of Evolent Health Inc, sale 11,000 shares at $30.00 during a trade that took place back on Nov 15 ’23, which means that McCarthy Daniel Joseph is holding 198,333 shares at $330,000 based on the most recent closing price.
Stock Fundamentals for EVH
Current profitability levels for the company are sitting at:
- -0.03 for the present operating margin
- 0.19 for the gross margin
The net margin for Evolent Health Inc stands at -0.05. The total capital return value is set at -0.03. Equity return is now at value -10.17, with -4.22 for asset returns.
Based on Evolent Health Inc (EVH), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is -1.16.
Currently, EBITDA for the company is 46.38 million with net debt to EBITDA at 5.1. When we switch over and look at the enterprise to sales, we see a ratio of 1.33. The receivables turnover for the company is 5.09for trailing twelve months and the total asset turnover is 0.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.02.
Conclusion
To wrap up, the performance of Evolent Health Inc (EVH) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
